English
Home > Products > (3H)-Isobenzofuranone, 5-phenoxy

China (3H)-Isobenzofuranone, 5-phenoxy Factory

We have been commitment to supply the competitive price ,excellent products and solutions high-quality, at the same time as fast delivery for (3H)-Isobenzofuranone, 5-phenoxy,CAS NO 57830-14-5,57830-14-5,Roxadustat intermediate,Roxadustat advance intermediate, We sincerely hope to determine some satisfactory interactions along with you from the in the vicinity of long run. We're going to hold you informed of our progress and anticipate building steady company relations along with you.
(3H)-Isobenzofuranone, 5-phenoxy, Our company promises: reasonable prices, short production time and satisfactory after-sales service, we also welcome you to visit our factory at any time you want. Wish we have a pleasant and long terms business together!!!

Related Products

Hot Products

  • 1,3-Dichloro-4-fluorobenzene

    1,3-Dichloro-4-fluorobenzene

    Product Name:1,3-Dichloro-4-fluorobenzene
    Molecular Formula:C6H3Cl2F
    Molecular Weight:164.99
    CAS Registry Number:1435-48-9
  • Ozanimod

    Ozanimod

    Product Name:Ozanimod
    Molecular Formula:C23H24N4O3
    Molecular Weight;404.46
    CAS Registry Number;1306760-87-1
  • (R)-3-Aminobutyric acid

    (R)-3-Aminobutyric acid

    Product Name:(R)-3-Aminobutyric acid
    Molecular Formula:C4H9NO2
    Molecular Weight:103.12
    CAS Registry Number:3775-73-3
  • Clinofibrate

    Clinofibrate

    Product Name:Clinofibrate
    Molecular Formula:C28H36O6
    Molecular Weight;468.58
    CAS Registry Number;30299-08-2
  • 1-ETHYL-7-CHLORO-6-FLUORO-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID

    1-ETHYL-7-CHLORO-6-FLUORO-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID

    Product Name:1-ETHYL-7-CHLORO-6-FLUORO-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID
    Molecular Formula:C12H9ClFNO3
    Molecular Weight:269.66
    CAS Registry Number:68077-26-9
  • Pyrazinamide

    Pyrazinamide

    Product Name:Pyrazinamide
    Molecular Formula:C5H5N3O
    Molecular Weight;123.11
    CAS Registry Number;98-96-4
  • Related Blog
  • Reviews

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Related Search

1(3H)-Isobenzofuranone, 5-phenoxy

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept